# Immunological Follow-up After SARS CoV2 Vaccination in Kidney Transplant Recipients

> **NCT04757883** · — · TERMINATED · sponsor: **University Hospital, Strasbourg, France** · enrollment: 37 (actual)

## Conditions studied

- Kidney Transplant Recipients

## Interventions

- **OTHER:** Study of the synthesis of antibodies directed against SARS

## Key facts

- **NCT ID:** NCT04757883
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-02-02
- **Primary completion:** 2024-11-01
- **Final completion:** 2024-11-01
- **Target enrollment:** 37 (ACTUAL)
- **Why stopped:** the required number of patients has been reached
- **Last updated:** 2025-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04757883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04757883, "Immunological Follow-up After SARS CoV2 Vaccination in Kidney Transplant Recipients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04757883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*